Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Financial Results:
Torrent Pharmaceuticals Ltd reported Revenues for Q1FY24 of ₹2,591.00 Crores up from ₹2,347.00 Crore year on year, a rise of 10.4%.
Total Expenses for Q1FY24 of ₹2,094.00 Crores up from ₹1,845.00 Crores year on year, a rise of 13.5%.
Consolidated Net Profit of ₹378.00 Crores up 6.78% from ₹354.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹11.17, up 6.79% from ₹10.46 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.